These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6655398)

  • 41. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis.
    Manneschi LI; Del Rosso A; Milia AF; Tani A; Nosi D; Pignone A; Generini S; Giacomelli R; Cerinic MM
    Rheumatology (Oxford); 2005 May; 44(5):607-13. PubMed ID: 15728417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic sclerosis.
    Pearson ME; Stechschulte DJ
    J Kans Med Soc; 1984 Jan; 85(1):13-7. PubMed ID: 6368712
    [No Abstract]   [Full Text] [Related]  

  • 43. Interstitial lung disease as the first manifestation of systemic sclerosis.
    van der Kamp R; Tak PP; Jansen HM; Bresser P
    Neth J Med; 2007 Nov; 65(10):390-4. PubMed ID: 18057462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Vital microscopy of nailfold capillaries in progressive scleroderma in relation to the clinical picture].
    Arizpe SR; Hornstein OP; Deinlein E
    Z Hautkr; 1984 May; 59(9):593-600. PubMed ID: 6730614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive systemic sclerosis: rare localization of the maxillofacial district.
    Cascone P; Rivaroli A; Vetrano S
    J Craniofac Surg; 1998 Sep; 9(5):472-6. PubMed ID: 9780919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure.
    Bijol V; Mendez GP; Hurwitz S; Rennke HG; Nosé V
    Am J Surg Pathol; 2006 May; 30(5):575-84. PubMed ID: 16699311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Survival and prognostic significance of a kidney lesion in systemic scleroderma].
    Guseva NG; Anikina NV; Balabanova RM
    Ter Arkh; 1982; 54(7):99-102. PubMed ID: 7135234
    [No Abstract]   [Full Text] [Related]  

  • 48. [Survey of 45 cases of systemic progressive sclerosis in adults].
    Baran E; Blizanowska A
    Pol Tyg Lek; 1972 Feb; 27(9):334-6. PubMed ID: 5019705
    [No Abstract]   [Full Text] [Related]  

  • 49. Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study.
    Levy Y; Amital H; Langevitz P; Nacci F; Righi A; Conforti L; Generini S; Matucci Cerinic M; Shoenfeld Y
    Arthritis Rheum; 2004 Mar; 50(3):1005-7. PubMed ID: 15022346
    [No Abstract]   [Full Text] [Related]  

  • 50. Vesical dysfunction in systemic sclerosis (scleroderma).
    Lazzeri M; Beneforti P; Benaim G; Corsi C; Ciambrone V; Marrapodi E; Mincione G; Turini D
    J Urol; 1995 Apr; 153(4):1184-7. PubMed ID: 7869494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [An electron microscopic study on lymphatic vessels in systemic scleroderma (author's transl)].
    Asano S; Takahasi M; Imabayashi K; Endo H
    Nihon Hifuka Gakkai Zasshi; 1980 Jan; 90(1):29-35. PubMed ID: 6965997
    [No Abstract]   [Full Text] [Related]  

  • 52. Ultrastructure of systemic sclerosis inflammatory myopathy.
    Finol HJ; Marquez A; Rivera H; Montes de Oca I; Muller B
    J Submicrosc Cytol Pathol; 1994 Apr; 26(2):245-53. PubMed ID: 8019948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progressive systemic sclerosis and malignant hypertension. Immunohistochemical study of renal lesions.
    FENNELL RH; REDDY CR; VAZQUEZ JJ
    Arch Pathol; 1961 Aug; 72():209-15. PubMed ID: 13698839
    [No Abstract]   [Full Text] [Related]  

  • 54. Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases.
    Malandrini A; Selvi E; Villanova M; Berti G; Sabadini L; Salvadori C; Gambelli S; De Stefano R; Vernillo R; Marcolongo R; Guazzi G
    J Rheumatol; 2000 May; 27(5):1203-6. PubMed ID: 10813288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Association of amyotrophic lateral sclerosis with scleroderma. Study of 2 cases].
    Ouhabi H; Bourazza A; Rouimi A; Boutaleb N; Mosseddaq R
    Rev Neurol (Paris); 1997 Dec; 153(12):790-1. PubMed ID: 9686272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
    Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Relationship between morphological, immunological and clinical findings in progressive scleroderma: muscular involvement].
    Meffert H; Barthelmes H; Klug H; Thormann T; Schwarz R; Sönnichesen N
    Dermatol Monatsschr; 1975 Jul; 161(7):556-66. PubMed ID: 1204912
    [No Abstract]   [Full Text] [Related]  

  • 59. [Changes in the lungs in progressive systemic sclerosis (scleroderma)].
    Kodolova IM; Preobrazhenskaia TM
    Arkh Patol; 1972; 34(4):59-65. PubMed ID: 5043687
    [No Abstract]   [Full Text] [Related]  

  • 60. Progressive systemic sclerosis: a case report from nigeria and review of african cases.
    Jacyk WK
    J Trop Med Hyg; 1979 Feb; 82(2):42-4. PubMed ID: 458907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.